Note on humans: These benefits are not established in humans , and the blend has not been studied in controlled human trials
In contrast, dietary fiber supplementation typically produces A1c reductions of 0.2-0.5% in systematic reviews, while berberine studies have shown variable reductions of approximately 0.5-1.0%, though many studies have methodological limitations
In recent years, novel therapies targeting p53, such as immunotherapy and gene therapy, have been developed, including vaccines, p53-specific antibodies, nanoparticles, siRNA delivery, and CRISPRCas9
The amount of weight regained depended on several factors, including the type of medication taken and the consistency of lifestyle changes such as diet and exercise
Passed: Confirms active ingredient concentration is within 10% of the label claim
In jedem Fall wird die Meldung weitergeleitet und gelangt binnen kurzer Frist in die groe Nebenwirkungsdatenbank der EU